{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:59:13Z","timestamp":1787061553419,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jaad.2019.05.096","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:12:27Z","timestamp":1560165147000},"page":"686-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients"],"prefix":"10.1016","volume":"81","author":[{"given":"Hui Kai","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Teng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Wen","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fook-Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.L.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon Chiat","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Wei","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu Ming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.05.096_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjmed.2016.03.022","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention","volume":"129","author":"Miliszewski","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2019.05.096_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2019.05.096_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2013treatment and outcome","volume":"65","author":"Yamane","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaad.2019.05.096_bib9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","article-title":"Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures","volume":"89","author":"de Prost","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.jaad.2019.05.096_bib11","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2019.05.096_bib12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","article-title":"Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"46","author":"Fromowitz","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.07.048","article-title":"Cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis: retrospective analysis of a cohort treated in a specialized referral center","volume":"76","author":"Lee","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.12607","article-title":"The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized center","volume":"169","author":"Lee","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib16","first-page":"h3868","article-title":"How to develop a more accurate risk prediction model when there are few events","volume":"351","author":"Pavlou","year":"2015","journal-title":"BMJ (Clinical Research Ed)"},{"key":"10.1016\/j.jaad.2019.05.096_bib17","first-page":"g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ (Clinical Research Ed)"},{"key":"10.1016\/j.jaad.2019.05.096_bib18","doi-asserted-by":"crossref","first-page":"e48307","DOI":"10.1371\/journal.pone.0048307","article-title":"Chronic medical conditions and risk of sepsis","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.05.096_bib19","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archinte.159.13.1437","article-title":"Risk factors for hospital-acquired Staphylococcus aureus bacteremia","volume":"159","author":"Jensen","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2019.05.096_bib20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib21","first-page":"1","article-title":"A retrospective analysis of infections and antibiotic treatment in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Diao","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2019.05.096_bib22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.143.12.1591-a","article-title":"High procalcitonin levels in patients with severe drug reactions","volume":"143","author":"Sfia","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/1346-8138.14488","article-title":"Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"45","author":"Wang","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2019.05.096_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00006231-200603000-00002","article-title":"Fever of unknown origin: a systematic review of the literature for 1995-2004","volume":"27","author":"Gaeta","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jaad.2019.05.096_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MD.0b013e31802fe858","article-title":"A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol","volume":"86","author":"Bleeker-Rovers","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.jaad.2019.05.096_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1309\/AJCP1MFYINQLECV2","article-title":"Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department","volume":"135","author":"Riedel","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2019.05.096_bib27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809020-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2019.05.096_bib28","doi-asserted-by":"crossref","first-page":"e11977","DOI":"10.1097\/MD.0000000000011977","article-title":"Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China","volume":"97","author":"Li","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.jaad.2019.05.096_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/322584","article-title":"Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study","volume":"33","author":"Garcia-Garmendia","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2019.05.096_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2334-10-228","article-title":"Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit","volume":"10","author":"Jung","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2019.05.096_bib31","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.jaad.2018.05.1258","article-title":"Wound management strategies in Stevens-Johnson syndrome\/toxic epidermal necrolysis: an unmet need","volume":"79","author":"Lee","year":"2018","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219309016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219309016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:13Z","timestamp":1759272673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219309016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0190962219309016"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.05.096","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735983462.793561788","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.05.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}